Guangzhou Preterm and Term Birth Cohort Study (GPTBC)

October 30, 2026 updated by: Li Cai, PhD, Sun Yat-sen University

The Guangzhou Preterm-Term Birth Cohort (GPTBC) is a prospective observational study of how early-life nutrition, environmental exposures, and family factors relate to the health and development of preterm and term infants and their mothers. Mother-infant pairs are followed from birth to 24 months. Researchers use questionnaires and biological samples to study human milk, microorganisms in the infant gut, physical growth, development, and allergic diseases, and whether these relationships differ between preterm and term infants. Findings may inform nutrition and health strategies for infants born at different gestational ages.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

The Guangzhou Preterm-Term Birth Cohort (GPTBC) is a single-center, prospective longitudinal observational study conducted at the Third Affiliated Hospital of Guangzhou Medical University. Mothers and their preterm or term infants were enrolled within 7 days after delivery and are followed primarily through 24 months of age; a subset receives additional follow-up beyond 24 months. The cohort was designed to recruit approximately equal numbers of preterm and term infants to characterize early-life exposures and health trajectories and to assess whether preterm birth modifies exposure-outcome associations.

The primary scientific focus is how human milk composition and other early-life nutritional and environmental exposures relate to infant growth, neuropsychological development, allergic diseases, and gut microbiome development. Serial human milk samples support measurements of nutritional components, 23 targeted human milk oligosaccharides, selected bioactive proteins, fatty acids, metabolomic and lipidomic profiles, microbial metagenomes, and exposomic profiles of environmental contaminants. Infant stool samples are analyzed using metagenomic sequencing. Additional stored biospecimens support related current and future research.

Repeated questionnaires capture maternal postpartum health, diet, lifestyle, psychological status, medication use, and breastfeeding; infant feeding, supplementation, illness, medication use, sleep, activity, screen exposure, and caregiving environment; and selected paternal and family characteristics. Child health is assessed longitudinally using anthropometry, standardized developmental assessments, eye tracking, parental reports of physician-diagnosed allergic diseases, and microbiome measures.

The study will examine exposure patterns and their changes over time, associations with maternal and child health, potential biological pathways, and differences between preterm and term infants.

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Sun Yat-sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Mother-infant pairs (term and preterm).

Description

Inclusion Criteria:

  1. Maternal age between 18 and 45 years.
  2. Resident in Guangzhou for at least one year.
  3. Gestational age at delivery ≥ 32 weeks and < 42 weeks (moderate-to-late preterm or term births).

Exclusion Criteria:

  1. Critical illness during pregnancy requiring admission to the intensive care unit.
  2. Unwilling or unable to breastfeed.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Preterm Birth Group

Mother-infant pairs in which the infant was born at 32 weeks 0 days to 36 weeks 6 days of gestation.

This cohort study have any no intervention.

Term Birth Group

Mother-infant pairs in which the infant was born at 37 weeks 0 days to 41 weeks 6 days of gestation.

This cohort study have any no intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Offspring Length/Height (cm)
Time Frame: Birth, 1 months, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.

Offspring length or height measured by a pediatrician.

Birth, 1 months, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
Offspring Weight (kg)
Time Frame: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Offspring weight measured using a calibrated scale.

Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
Offspring Head Circumference (cm)
Time Frame: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Offspring head circumference measured by a pediatrician.

Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
Offspring Body Mass Index (kg/m²)
Time Frame: Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Calculated as weight (kg) divided by the square of length or height (in meters).

Birth, 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.
Neurodevelopmental outcome - Gesell Developmental Schedules (GDS)
Time Frame: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.

Developmental Quotients (DQ) for each developmental domain, assessed by the Gesell Developmental Schedules (GDS) administered by a pediatrician. DQ is calculated as (developmental age / chronological age or corrected age) × 100, with higher DQ indicating better development. Domains include: (1) adaptive, (2) gross motor, (3) fine motor, (4) language, and (5) personal-social.

1 month, 3 months, 6 months, 8 months, 12 months, 18 months, and 24 months of age.
Neurodevelopmental outcome - Ages and Stages Questionnaires (ASQ)
Time Frame: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Parent-reported scores (0-60) for each developmental domain, assessed using the Ages and Stages Questionnaires (ASQ). Higher scores indicate better development. Domains include: (1) communication, (2) gross motor, (3) fine motor, (4) problem-solving, and (5) personal-social.

1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Cognitive Attention Patterns - Sufficient Fixation Trials (number)
Time Frame: 6 months, 8 months, and 12 months of age.

Number of trials in which the fixation duration on specific Areas of Interest (social and non-social) exceeds 30% of the total fixation duration on the entire screen, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator indicates adequate attentional engagement with the presented social and non-social stimuli.

6 months, 8 months, and 12 months of age.
Social Cognitive Attention Patterns - First Fixation Count (number)
Time Frame: 6 months, 8 months, 12 months of age.

Number of times the first fixation following stimuli onset lands on specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator captures initial attentional orienting and reflects the salience of the presented social and non-social stimuli.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - First Fixation Duration (seconds)
Time Frame: 6 months, 8 months, 12 months of age.

Duration (in seconds) of the first fixation within specific Areas of Interest (social and non-social) following stimulus onset, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects early-stage attentional processing and the efficiency of initial stimulus engagement.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - Total Fixation Count (number)
Time Frame: 6 months, 8 months, 12 months of age.

Total number of discrete fixation events occurring within specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects the overall frequency of attentional engagement with the presented social and non-social stimuli.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - Total Fixation Duration (seconds)
Time Frame: 6 months, 8 months, 12 months of age.

Cumulative duration (in seconds) of all fixations occurring within specific Areas of Interest (social and non-social), measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects overall attentional allocation to the presented social and non-social stimuli.

6 months, 8 months, 12 months of age.
Social Cognitive Attention Patterns - Fixation Duration Proportion (%)
Time Frame: 6 months, 8 months, 12 months of age.

Percentage of total fixation time allocated to social or non-social Areas of Interest, calculated as (total fixation time on social or non-social Areas of Interest / total fixation time on all Areas of Interest) × 100, measured using a Tobii Pro Spectrum eye-tracker across biological motion, joint attention, and visual preference paradigms. This eye-tracking indicator reflects relative attentional preference between social and non-social stimuli.

6 months, 8 months, 12 months of age.
Number of Participants with Physician-Diagnosed Allergic Diseases
Time Frame: 1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Number of participants who experience at least one episode of physician-diagnosed allergic diseases during the follow-up period, including eczema or atopic dermatitis, cow's milk protein allergy, other food allergies, allergic rhinitis, and asthma, as diagnosed by a physician and reported by parents, and confirmed by medical records.

1 month, 3 months, 6 months, 8 months, 12 months, 18 months, 24 months of age.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Li Cai, Ph.D, Sun Yat-sen University
  • Principal Investigator: Lizi Lin, Ph.D, Sun Yat-sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 21, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

April 14, 2026

First Submitted That Met QC Criteria

August 5, 2026

First Posted (Actual)

August 10, 2026

Study Record Updates

Last Update Posted (Actual)

November 3, 2026

Last Update Submitted That Met QC Criteria

October 30, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.